»Ê¼Ò»ªÈË
Close
Study
Research
Engage
About
Give
»Ê¼Ò»ªÈËews
Home
Home
Latest news
UCL in the media
Services for media
Student news
Staff news
Tell us your story
Contact us
»Ê¼Ò»ªÈËews
EU regulator rejects Alzheimer's drug lecanemab
Home
Latest news
UCL in the media
Services for media
Student news
Staff news
Tell us your story
Contact us
Home
Latest news
UCL in the media
Services for media
Student news
Staff news
Tell us your story
Contact us
»Ê¼Ò»ªÈËews
EU regulator rejects Alzheimer's drug lecanemab
EU regulator rejects Alzheimer's drug lecanemab
29 July 2024
"I am sure we will now see rich people with early Alzheimer’s disease flying to the US or other jurisdictions for treatment," says Professor Sir John Hardy (UCL Queen Square Institute of Neurology) who is critical of the EU's decision.
, , , ,Ìý
Follow us
Ìý
Ìý
Ìý
Ìý
Ìý
Ìý
Ìý